NDC properties for "ampicillin (as ampicillin sodium) 1 GM / sulbactam (as sulbactam sodium) 0.5 GM Injection" (RxCUI 1659592)
About this data
The tables show NDC propoerties for ampicillin (as ampicillin sodium) 1 GM / sulbactam (as sulbactam sodium) 0.5 GM Injection with the RxCUI 1659592
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for ampicillin (as ampicillin sodium) 1 GM / sulbactam (as sulbactam sodium) 0.5 GM Injection (RxCUI 1659592)
ANDA | ANDA065176 |
---|---|
ANDA | ANDA065222 |
ANDA | ANDA065310 |
ANDA | ANDA065406 |
ANDA | ANDA090340 |
ANDA | ANDA090349 |
ANDA | ANDA090579 |
ANDA | ANDA201024 |
ANDA | ANDA201406 |
MMSL_CODE | BD1345 |
MMSL_CODE | CD1345 |
RxCUI | 1659592 |
SNOMEDCT | 370418003 |
SPL_SET_ID | 006f9a3f-b4e3-4aa5-ac65-6cc3d3e2582d |
SPL_SET_ID | 16fdfdb9-9e26-48d0-8838-570d30c8e897 |
SPL_SET_ID | 1e5004f1-e79e-4e0b-9f3f-25f6bbc15255 |
SPL_SET_ID | 6ae2c4a1-f704-4642-bbdd-f69a9ef07605 |
SPL_SET_ID | 7161f386-6373-4db5-8dfd-d7ddf38ec2f1 |
SPL_SET_ID | 71b45af0-7363-4c93-8106-0a2220e62d9e |
SPL_SET_ID | 942ea2a7-8a1b-405e-a802-2ff0debc388b |
SPL_SET_ID | 9a722de6-9dc0-4fb9-b63a-225385aa3314 |
SPL_SET_ID | a67ae347-487d-4751-a841-b321e81db26f |
SPL_SET_ID | ac6f8158-9d7e-4b99-af3c-0407c5287b57 |
SPL_SET_ID | adc92303-b62b-41c8-becf-9c3a4e8c3a6b |
SPL_SET_ID | bb78b01f-b235-4a3e-b3d2-24543d3fd56c |
SPL_SET_ID | d3026cc0-95d8-44cf-be47-b5ebb8fd4568 |
SPL_SET_ID | d4e9ca30-7af3-42ec-e053-2995a90afe1f |
SPL_SET_ID | dc374fa4-350b-425d-a7db-7099fdc64cf1 |
SPL_SET_ID | e6cf14a8-3ed9-4a7a-ba69-be0b794cbdc4 |
SPL_SET_ID | f8e534d8-5bb8-47c4-a11e-ec67f0609d1d |
VUID | 4008598 |
Prescribable Synonym | ampicillin / sulbactam 1.5 GM Injection |
RXNAV_STR | ampicillin 1000 MG / sulbactam 500 MG Injection |
RxNorm Name | ampicillin 1000 MG / sulbactam 500 MG Injection |
RxNorm Synonym | ampicillin (as ampicillin sodium) 1 GM / sulbactam (as sulbactam sodium) 0.5 GM Injection |
RxNorm Synonym | ampicillin 1 GM / sulbactam 0.5 GM Injection |
Related queries | Interactions (for RxCUI 1659592) |
NDC Properties
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288003120
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-20 |
NDC Item | 71288003120 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003121
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-21 |
NDC Item | 71288003121 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-21) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-20) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003191
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-91 |
NDC Item | 71288003191 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 71288003192
NDC 9 | 71288-031 |
---|---|
NDC 10 | 71288-031-92 |
NDC Item | 71288003192 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-031-92) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-031-91) |
ANDA | ANDA065222 |
FDA SPL set id | 749843 |
FDA SPL set id | 787470 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-29 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 71288-031 |
NDC Item 72485041601
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-01 |
NDC Item | 72485041601 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72485041610
NDC 9 | 72485-416 |
---|---|
NDC 10 | 72485-416-10 |
NDC Item | 72485041610 |
Packaging | 10 VIAL in 1 CARTON (72485-416-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72485-416-01) |
ANDA | ANDA201024 |
COLORTEXT | white(off-white) |
Color | C48325 __ |
FDA SPL set id | 720326 |
Labeler | Armas Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-21 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72485-416 |
NDC Item 72572002101
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-01 |
NDC Item | 72572002101 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72572002110
NDC 9 | 72572-021 |
---|---|
NDC 10 | 72572-021-10 |
NDC Item | 72572002110 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-021-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72572-021-01) |
ANDA | ANDA090579 |
FDA SPL set id | 679256 |
Labeler | Civica, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-03-11 |
Marketing effective time low | 2022-01-10 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 72572-021 |
NDC Item 72603022001
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-01 |
NDC Item | 72603022001 |
Packaging | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | active |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 72603022010
NDC 9 | 72603-220 |
---|---|
NDC 10 | 72603-220-10 |
NDC Item | 72603022010 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-220-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (72603-220-01) |
ANDA | ANDA065222 |
FDA SPL set id | 793796 |
Labeler | NorthStar Rx, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-03-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 72603-220 |
NDC Item 82449051301
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-01 |
NDC Item | 82449051301 |
Packaging | 1 VIAL in 1 CARTON (82449-513-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 82449051302
NDC 9 | 82449-513 |
---|---|
NDC 10 | 82449-513-02 |
NDC Item | 82449051302 |
Packaging | 10 VIAL in 1 CARTON (82449-513-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 803546 |
Labeler | Steriscience Specialties Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 82449-513 |
NDC Item 00409268901
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-01 |
NDC Item | 00409268901 |
Packaging | 10 VIAL in 1 TRAY (0409-2689-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-2689-21) |
ANDA | ANDA065310 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2006-07-25 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268921
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-21 |
NDC Item | 00409268921 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00409268949
NDC 9 | 0409-2689 |
---|---|
NDC 10 | 0409-2689-49 |
NDC Item | 00409268949 |
ANDA | ANDA065241 |
FDA SPL set id | 806154 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2013-10-01 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0409-2689 |
NDC Item 00641611601
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-01 |
NDC Item | 00641611601 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611610
NDC 9 | 0641-6116 |
---|---|
NDC 10 | 0641-6116-10 |
NDC Item | 00641611610 |
Packaging | 10 VIAL in 1 CARTON (0641-6116-10) / 1.5 g in 1 VIAL (0641-6116-01) |
ANDA | ANDA065406 |
FDA SPL set id | 811866 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6116 |
NDC Item 00641611901
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-01 |
NDC Item | 00641611901 |
Packaging | 1.5 g in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641611910
NDC 9 | 0641-6119 |
---|---|
NDC 10 | 0641-6119-10 |
NDC Item | 00641611910 |
Packaging | 10 VIAL in 1 CARTON (0641-6119-10) / 1.5 g in 1 VIAL (0641-6119-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440588 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6119 |
NDC Item 00641612201
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-01 |
NDC Item | 00641612201 |
Packaging | 4 mL in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00641612210
NDC 9 | 0641-6122 |
---|---|
NDC 10 | 0641-6122-10 |
NDC Item | 00641612210 |
Packaging | 10 VIAL in 1 CARTON (0641-6122-10) / 4 mL in 1 VIAL (0641-6122-01) |
ANDA | ANDA065406 |
FDA SPL set id | 440293 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-12-22 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0641-6122 |
NDC Item 00781303270
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-70 |
NDC Item | 00781303270 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 00781303295
NDC 9 | 0781-3032 |
---|---|
NDC 10 | 0781-3032-95 |
NDC Item | 00781303295 |
Packaging | 10 VIAL in 1 CARTON (0781-3032-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-3032-70) |
ANDA | ANDA065241 |
FDA SPL set id | 526593 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-05-31 |
Marketing effective time low | 2006-07-25 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 0781-3032 |
NDC Item 25021014220
NDC 9 | 25021-142 |
---|---|
NDC 10 | 25021-142-20 |
NDC Item | 25021014220 |
Packaging | 10 VIAL in 1 CARTON (25021-142-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065406 |
FDA SPL set id | 612973 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2010-06-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 25021-142 |
NDC Item 25021018620
NDC 9 | 25021-186 |
---|---|
NDC 10 | 25021-186-20 |
NDC Item | 25021018620 |
Packaging | 10 VIAL in 1 CARTON (25021-186-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 549185 |
Labeler | Sagent Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2021-03-31 |
Marketing effective time low | 2017-08-15 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 25021-186 |
NDC Item 44567021010
NDC 9 | 44567-210 |
---|---|
NDC 10 | 44567-210-10 |
NDC Item | 44567021010 |
Packaging | 10 VIAL in 1 CARTON (44567-210-10) / 10 mL in 1 VIAL |
ANDA | ANDA065176 |
FDA SPL set id | 803837 |
Labeler | WG Critical Care, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2005-11-30 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 44567-210 |
NDC Item 55150011601
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-01 |
NDC Item | 55150011601 |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011610
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-10 |
NDC Item | 55150011610 |
Packaging | 10 VIAL in 1 CARTON (55150-116-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150011620
NDC 9 | 55150-116 |
---|---|
NDC 10 | 55150-116-20 |
NDC Item | 55150011620 |
Packaging | 10 VIAL in 1 CARTON (55150-116-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA090349 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 705782 |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-02-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-116 |
NDC Item 55150017899
NDC 9 | 55150-178 |
---|---|
NDC 10 | 55150-178-99 |
NDC Item | 55150017899 |
Packaging | 10 BOTTLE in 1 BOX (55150-178-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE |
ANDA | ANDA090340 |
COLORTEXT | WHITE(White to Off-white) |
Color | C48325 __ |
FDA SPL set id | 790857 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-09-13 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 55150-178 |
NDC Item 63323036820
NDC 9 | 63323-368 |
---|---|
NDC 10 | 63323-368-20 |
NDC Item | 63323036820 |
Packaging | 10 VIAL in 1 CARTON (63323-368-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA065222 |
FDA SPL set id | 460623 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2016-05-05 |
Marketing effective time low | 2005-11-29 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 63323-368 |
NDC Item 66794020602
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-02 |
NDC Item | 66794020602 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794020641
NDC 9 | 66794-206 |
---|---|
NDC 10 | 66794-206-41 |
NDC Item | 66794020641 |
Packaging | 10 VIAL in 1 CARTON (66794-206-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-206-02) |
ANDA | ANDA090579 |
FDA SPL set id | 683064 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2019-05-20 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-206 |
NDC Item 66794024102
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-02 |
NDC Item | 66794024102 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 66794024141
NDC 9 | 66794-241 |
---|---|
NDC 10 | 66794-241-41 |
NDC Item | 66794024141 |
Packaging | 10 VIAL in 1 CARTON (66794-241-41) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (66794-241-02) |
ANDA | ANDA090579 |
FDA SPL set id | 695619 |
Labeler | Piramal Critical Care Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-05-15 |
Marketing effective time low | 2023-01-01 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 66794-241 |
NDC Item 67457034810
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-10 |
NDC Item | 67457034810 |
Packaging | 10 VIAL in 1 CARTON (67457-348-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67457034815
NDC 9 | 67457-348 |
---|---|
NDC 10 | 67457-348-15 |
NDC Item | 67457034815 |
Packaging | 1 VIAL in 1 CARTON (67457-348-15) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
ANDA | ANDA201024 |
FDA SPL set id | 544815 |
Labeler | Mylan Institutional LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2023-10-31 |
Marketing effective time low | 2014-04-08 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 67457-348 |
NDC Item 67850013000
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-00 |
NDC Item | 67850013000 |
Packaging | 1 in 1 VIAL, GLASS |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 67850013010
NDC 9 | 67850-130 |
---|---|
NDC 10 | 67850-130-10 |
NDC Item | 67850013010 |
Packaging | 10 VIAL, GLASS in 1 CARTON (67850-130-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (67850-130-00) |
ANDA | ANDA201406 |
FDA SPL set id | 770928 |
Labeler | Methapharm, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-01 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 67850-130 |
NDC Item 70594008101
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-01 |
NDC Item | 70594008101 |
Packaging | 1 in 1 VIAL |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 70594008102
NDC 9 | 70594-081 |
---|---|
NDC 10 | 70594-081-02 |
NDC Item | 70594008102 |
Packaging | 10 VIAL in 1 CARTON (70594-081-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-081-01) |
ANDA | ANDA090579 |
FDA SPL set id | 687752 |
Labeler | Xellia Pharmaceuticals USA LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-01-10 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 70594-081 |
NDC Item 71288000520
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-20 |
NDC Item | 71288000520 |
Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-005-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (71288-005-21) |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |
NDC Item 71288000521
NDC 9 | 71288-005 |
---|---|
NDC 10 | 71288-005-21 |
NDC Item | 71288000521 |
Packaging | 1 in 1 VIAL, SINGLE-DOSE |
ANDA | ANDA090579 |
FDA SPL set id | 770198 |
Labeler | Meitheal Pharmaceuticals Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-07-31 |
Marketing effective time low | 2022-01-17 |
Marketing status | COMPLETED |
Related queries | Properties for NDC 9 71288-005 |